Current testing practices in the pharmaceutical industry exploit social and racial inequities.
Pending federal legislation would improve food information for consumers with gluten sensitivity.
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Regulators strive to keep our animal companions’ food safe, but gaps remain.
Government watchdog finds that FDA is not properly inspecting imported seafood.
Lawyer proposes a new legal framework for reviewing FDA’s refusal to regulate lethal injection drugs.
FDA should take steps to strengthen the regenerative medicine industry.
Edible insects may become essential in the wake of the COVID-19 crisis, but FDA regulation is lacking.
A federal task force proposes regulatory solutions to mitigate drug shortages.
FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.
Unlike new drugs and devices, combination products may fall through the regulatory cracks.
The FTC and Justice Department must change their interpretation of antitrust laws to protect fair competition in agriculture.